Published in Cancer Weekly, July 15th, 1996
Because of their broad host range, high titers, and capacity for large DNA inserts, adenoviral vectors are attractive for gene transfer. Unfortunately, their effectiveness is limited by host anti-viral immune responses.
J.S. Bromberg et al. presented data at the joint meeting of the American Society for Biochemistry and Molecular Biology, the American Society for Investigative Pathology, and the American Association of Immunologists, held June 2-6, 1996, in New Orleans, Louisiana, which showed that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.